You have 9 free searches left this month | for more free features.

gene therapy

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Temporomandibular Joint Dysfunction Syndrome Trial in Murcia (Manual therapy, Postural exercises)

Completed
  • Temporomandibular Joint Dysfunction Syndrome
  • Manual therapy
  • Postural exercises
  • Murcia, Spain
    University Of Murcia
Jun 8, 2023

Carcinoma, Hepatocellular Trial in Worldwide (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Los Angeles, California
  • +138 more
Aug 22, 2022

Prostate Cancer Trial in United States (Degarelix, stereotactic body radiosurgery (SBRT))

Active, not recruiting
  • Prostate Cancer
  • Miami, Florida
  • +9 more
Mar 1, 2022

Thyroid Hormones' Effect on Thyrotropin Incretion in Confirmed

Unknown status
  • Hypothyroidism
  • Hyperthyroidism
    • Bietigheim, BW, Germany
    • +2 more
    Oct 6, 2020

    Eating Disorders Trial in London (Avatar Therapy)

    Completed
    • Eating Disorders
    • Avatar Therapy
    • London, United Kingdom
      King's College London
    Feb 28, 2022

    Intra-cardiac Thrombus, STEMI, Heart Failure Trial in France, Réunion (Vitamin K antagonist, Direct oral anticoagulant)

    Not yet recruiting
    • Intra-cardiac Thrombus
    • +2 more
    • Vitamin K antagonist
    • Direct oral anticoagulant
    • Angers, France
    • +33 more
    Apr 11, 2023

    Lymphedema Arm Trial (BioBridge)

    Not yet recruiting
    • Lymphedema Arm
    • BioBridge
    • (no location specified)
    Apr 20, 2023

    Heart Failure Trial in Pointe-à-Pitre, Fort-de-France (Patient with no ventricular hypertrophy)

    Not yet recruiting
    • Heart Failure
    • Patient with no ventricular hypertrophy
    • Pointe-à-Pitre, Guadeloupe
    • +1 more
    Aug 11, 2022

    Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor Stage II Extranodal Marginal

    Completed
    • Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
    • +2 more
    • Radiation Therapy
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 25, 2022

    Bladder Cancer, Squamous Cell Carcinoma of the Bladder, Stage III Bladder Cancer Trial in Atlanta (3D conformal radiation

    Terminated
    • Bladder Cancer
    • +4 more
    • 3D conformal radiation therapy
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Feb 14, 2022

    FIGO Stage III and IV Ovarian Cancer, FIGO Stage III and IV Fallopian Tube Cancer, FIGO Stage III Primary Peritoneal Cancer

    Completed
    • FIGO Stage III and IV Ovarian Cancer
    • +2 more
    • ALT-803 Subcutaneous
    • ALT-803 Intraperitoneal
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Oct 5, 2022

    Immune Function and PD-1 Antibody Therapy Efficacy Predictors on

    Recruiting
    • Secondary Hemophagocytic Lymphohistiocytosis
    • Chronic Active Epstein-Barr Virus Infection
    • No intervention
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    May 2, 2023

    PASS of Paediatric Patients Initiating Selumetinib

    Recruiting
    • Neurofibromatosis Type 1
      • Angers, France
      • +3 more
      Jan 12, 2023

      NIAID Clinical Center Genomics Opportunity Protocol

      Completed
      • Immune Disorders
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 12, 2023

        Depression, Anxiety, Stress Disorders, Post-Traumatic Trial in Winnipeg (MxN-9 HD-tES Stimulator (Soterix Inc.), Sham

        Not yet recruiting
        • Depression
        • +2 more
        • MxN-9 HD-tES Stimulator (Soterix Inc.)
        • Sham Stimulation
        • Winnipeg, Manitoba, Canada
          University of Manitoba
        Oct 31, 2022

        Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia

        Recruiting
        • Acute Lymphoblastic Leukemia, in Relapse
        • +5 more
        • CAR-20/19-T cells (1 x 10^5 CAR-20/19-T cells/kg)
        • +4 more
        • Milwaukee, Wisconsin
          Medical College of Wisconsin
        Sep 22, 2022

        COVID-19 Pandemic Trial in Baghdad (Colchicine 0.5 MG)

        Completed
        • COVID-19 Pandemic
        • Colchicine 0.5 MG
        • Baghdad, Iraq
          University of Baghdad
        Nov 27, 2021

        r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase

        Not yet recruiting
        • B-cell Lymphoma
        • Beijing, Beijing, China
          Deparment of Hematology, Peking University People's Hospital
        Aug 9, 2022

        Breast Cancer Trial in Beijing (18F-FES PET/CT scan)

        Recruiting
        • Breast Cancer
        • 18F-FES PET/CT scan
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Nov 4, 2022

        Spinal Cord Injuries, Muscle Pareses, Fall Trial in Toronto (Activity-based rehabilitation+electrical stimulation)

        Not yet recruiting
        • Spinal Cord Injuries
        • +2 more
        • Activity-based rehabilitation+electrical stimulation
        • Toronto, Ontario, Canada
          Toronto Rehabilitation Institute-Lyndhurst Center
        Jul 11, 2023

        Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)

        Completed
        • Pancreas Cancer
        • +6 more
        • Rozzano, Milan, Italy
          Istituto Clinico Humanitas
        Sep 9, 2022

        Dementia, Dementia, Vascular, Dementia, Mixed Trial in London (Virtual Individual Cognitive Simulation Therapy)

        Active, not recruiting
        • Dementia
        • +10 more
        • Virtual Individual Cognitive Simulation Therapy
        • London, United Kingdom
          UCL
        Mar 24, 2022

        Psoriasis Trial in Winston-Salem (transcutaneous electrical nerve stimulation (TENS) unit)

        Active, not recruiting
        • Psoriasis
        • transcutaneous electrical nerve stimulation (TENS) unit
        • Winston-Salem, North Carolina
          Wake Forest University Health Sciences
        Jan 31, 2023

        Nasopharyngeal Carcinoma Trial in Guangzhou (Camrelizumab, gemcitabin, cisplatin, Stereotactic Body Radiotherapy, Intensity

        Recruiting
        • Nasopharyngeal Carcinoma
        • Camrelizumab, gemcitabin, cisplatin
        • Stereotactic Body Radiotherapy, Intensity modulated-radiotherapy
        • Guangzhou, Guangdong, China
          Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
        Jun 19, 2022

        Multiple Myeloma Trial in Seoul (Carfilzomib 56 MG [Kyprolis], Pomalidomide, Dexamethasone)

        Recruiting
        • Multiple Myeloma
        • Carfilzomib 56 MG [Kyprolis]
        • +2 more
        • Seoul, Korea, Republic of
          Samsung Medical Center
        Aug 19, 2022